IMBA – INSTITUTE OF MOLECULAR BIOTECHNOLOGY

IMBA – INSTITUTE OF MOLECULAR BIOTECHNOLOGY

ÜABOUT IMBA

IMBA – Institute of Molecular Biotechnology is one of the leading biomedical research institutes in Europe focusing on cutting-edge functional genomics and stem cell technologies. IMBA is located at the Vienna BioCenter, the vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a basic research institute of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research.

ÜABOUT VIENNA BIOCENTER

The Vienna BioCenter (VBC) is a leading life sciences location in Europe, offering an extraordinary combination of research, education and business on a single campus. About 1,700 employees, including more than 1,300 scientist from 70 nations create a highly dynamic environment of international standards.www.viennabiocenter.org

EDU

CATI

ON

> 1,500 Students

BUSI

NES

S

25 Biotech companies

RESE

ARCH 96

Research groups

IMBA – INSTITUTE OF MOLECULAR BIOTECHNOLOGY

ÜRESEARCH GROUPS

Mechanisms and biology of RNA silencing. Post-transcriptional gene regulation, RNA biochemistry, RNP enzymology, RNA modifications, small non-coding RNAs

Molecular determinants of biological idiosyncrasy. Genomics, selfish elements, speciation, hybrids, complex traits

Assembly and function of the cell division machinery. Mitosis, chromosomes, cell organelles, high-content screening, computer vision, biophysics

Mechanisms of plasticity after brain injury. Structural plasticity, adaptive remodeling, neural networks, brain connectivity

Starting in 2020

Transposon silencing & heterochromatin formation by small RNAs. Transposons, piRNAs, heterochromatin, epigenetics, small RNAs

Theoretical models of chromosome structure. Biophysics, polymer models, computational biology, chromosomes, mitosis, DNA repair, gene regulation

Functional genomics in embryonic stem cells. Haploid, screen, CRISPR/Cas, embryonic stem cells, cell fate

Ü SCIENTIFIC EXCELLENCE

PUBLICATIONS* ERC GRANTS*Starting 7Advanced 4Consolidator 3Proof of Concept 2

EMBO MEMBERSHIPS* EMBO full members 5EMBO YIPs (active) 2

32,5% of all IMBA publications are in the Top 10% most cited articles in their respective fields Source: InCites dataset updated Sep 26, 2019

>950

Publications since IMBA´s foundation in 2003

*as of 10/2019

STEFAN AMERES

ALEJANDRO BURGA

DANIEL GERLICH

SOFIA GRADE

JULIUS BRENNECKE

ANTON GOLOBORODKO

ULRICH ELLING

Linear ubiquitination in inflammation, cell death and autophagy. Ubiquitin signal, E3 ligase, immune responses, cell death, autophagy

FUMIYO IKEDA

IMBA – INSTITUTE OF MOLECULAR BIOTECHNOLOGY

Scientific Director (interim)Brain development and disease. Stem cells, brain, organoids, cancer

Chromatin reprogramming in totipotent stem cells. Totipotency, stem cells, chromatin organization, epigenetic reprogramming, zygotes, oocytes

Homeostatic regulation of adult stem cells. Adult stem cells, organoids, genetics, E3 ubiquitin ligases, cancer

Founding Director (2002 - 2018)Modeling human disease. Embryonic stem cells, organoids, development, cancer, disease, mouse models

Systemic regulation of adult neurogenesis. Brain, stem cells, niche, metabolism, memory, emotions

Ü STAFF

Macromolecular phase separation in germ cell fate.Phase separation, non-membrane-bound compartments, P granules, nuage, germline cell fate, in vitro reconstitution

SHAMBADITYA SAHA

Synthetic development. Blastoids, stem cells, self-organisation

NICOLAS RIVRON

JÜRGEN KNOBLICH

KIKUË TACHIBANA

BON-KYOUNG KOO

JOSEF PENNINGER

NOELIA URBÁN

male50%

female50%

Gender distribution* Nationalities*

41total

North America3

Europe196

Africa2

Asia26

South America3

Principal Investigators15

Postdocs39

PhD Students45

Scientific Service57

Technicians28

Administration33

Master/Diploma Students13

Functions*

230employees

*as of 10/2019

Molecular control of human organogenesis. Organogenesis, human pluripotent stem cells, mesoderm, cardiac, adipose, patterning

SASHA MENDJAN

male50%

female50%

Gender distribution* Nationalities*

41total

North America3

Europe196

Africa2

Asia26

South America3

IMBA – INSTITUTE OF MOLECULAR BIOTECHNOLOGY

WWW.IMBA.OEAW.AC.AT DR. BOHR-GASSE 3 | VIENNA BIOCENTER | 1030 VIENNA, AUSTRIA | T: +43 1 79044 | F: +43 1 79044-100IBAN: AT22 1100 0012 7034 1900 | BIC: BKAUATWW

Ü SCIENTIFIC FACILITIES

IMBA is committed to the success of its research groups. We provide strong administrative and scientific support that includes a broad array of cutting-edge services and facilities. Facilities that are available to IMBA researchers include:

• Bioinformatics• BioOptics• Electron Microscopy• Metabolomics• Next Generation Sequencing• Protein Chemistry• Stem Cell Core Facility

www.imba.oeaw.ac.at/scientific-facilities/www.vbcf.ac.at

Ü BUDGET 2019

ÜMORE INFORMATION

www.imba.oeaw.ac.at

Ü EDUCATION & TRAINING

Together with our neighbours at the Vienna BioCenter, we offer international trainings for all levels of education. Our training programmes are designed to prime and/or advance learning of critical skills for your career.Moreover, you can profit from a comprehensive seminar programme with top-notch international speakers.

www.training.vbc.ac.at

VBC PhD Programme

PostDoc Opportunities

Master Projects

VBC Summer School

Others (incl. private funding)9%

Austrian Academy of Sciences51%

Research Grants24%

Revenues16%

35Mio €